Nuti Sudhakar V, Li Shu-Xia, Xu Xiao, Ott Lesli S, Lagu Tara, Desai Nihar R, Murugiah Karthik, Duan Michael, Martin John, Kim Nancy, Krumholz Harlan M
Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06516, USA.
Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, 1 Church Street, Suite 200, New Haven, CT, 06510, USA.
BMC Health Serv Res. 2019 Mar 25;19(1):190. doi: 10.1186/s12913-019-4018-0.
Efforts to decrease hospitalization costs could increase post-acute care costs. This effect could undermine initiatives to reduce overall episode costs and have implications for the design of health care under alternative payment models.
Among Medicare fee-for-service beneficiaries aged ≥65 years hospitalized with acute myocardial infarction (AMI) between July 2010 and June 2013 in the Premier Healthcare Database, we studied the association of in-hospital and post-acute care resource utilization and outcomes by in-hospital cost tertiles.
Among patients with AMI at 326 hospitals, the median (range) of each hospital's mean per-patient in-hospital risk-standardized cost (RSC) for the low, medium, and high cost tertiles were $16,257 ($13,097-$17,648), $18,544 ($17,663-$19,875), and $21,831 ($19,923-$31,296), respectively. There was no difference in the median (IQR) of risk-standardized post-acute payments across cost-tertiles: $5014 (4295-6051), $4980 (4349-5931) and $4922 (4056-5457) for the low (n = 90), medium (n = 98), and high (n = 86) in-hospital RSC tertiles (p = 0.21), respectively. In-hospital and 30-day mortality rates did not differ significantly across the in-hospital RSC tertiles; however, 30-day readmission rates were higher at hospitals with higher in-hospital RSCs: median = 17.5, 17.8, and 18.0% at low, medium, and high in-hospital RSC tertiles, respectively (p = 0.005 for test of trend across tertiles).
In our study of patients hospitalized with AMI, greater resource utilization during the hospitalization was not associated with meaningful differences in costs or mortality during the post-acute period. These findings suggest that it may be possible for higher cost hospitals to improve efficiency in care without increasing post-acute care utilization or worsening outcomes.
降低住院费用的努力可能会增加急性后期护理费用。这种影响可能会破坏降低总体治疗费用的举措,并对替代支付模式下的医疗保健设计产生影响。
在2010年7月至2013年6月期间,在Premier医疗数据库中因急性心肌梗死(AMI)住院的≥65岁医疗保险按服务付费受益人中,我们按住院费用三分位数研究了住院和急性后期护理资源利用与结局之间的关联。
在326家医院的AMI患者中,低、中、高费用三分位数的每家医院平均每位患者的住院风险标准化成本(RSC)的中位数(范围)分别为16,257美元(13,097 - 17,648美元)、18,544美元(17,663 - 19,875美元)和21,831美元(19,923 - 31,296美元)。各费用三分位数的风险标准化急性后期支付中位数(IQR)无差异:低(n = 90)、中(n = 98)、高(n = 86)住院RSC三分位数分别为5014美元(4295 - 6051美元)、4980美元(4349 - 5931美元)和4922美元(4056 - 5457美元)(p = 0.21)。住院RSC三分位数之间的住院和30天死亡率无显著差异;然而,住院RSC较高的医院30天再入院率更高:低、中、高住院RSC三分位数分别为中位数 = 17.5%、17.8%和18.0%(三分位数趋势检验p = 0.005)。
在我们对AMI住院患者的研究中,住院期间更多的资源利用与急性后期的费用或死亡率的显著差异无关。这些发现表明,成本较高的医院有可能在不增加急性后期护理利用率或不恶化结局的情况下提高护理效率。